Explore more publications!

Consumer World Report Press Releases

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
Ecorobotix Showcases World-First AI Capability for Safe, Targeted Use of Non-Selective Contact Herbicides at Agritechnica
Fintradix Releases Quarterly Performance Report Highlighting Double-Digit Growth
Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Decrease In October 2025 of 0.8% Compared to 2024
Ajarro Advises Amazon Sellers on Adapting to New API Access Fees and Reporting Changes
Interview with Product Designer Sofia von Hauske, Unpacking the Future of Human-Centered Technology
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living
Beyond Meat® to Report Third Quarter 2025 Financial Results on November 10, 2025 and Hold Conference Call on November 11, 2025
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Quanex Building Products Corporation Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action – NX
Dorel Reports Third Quarter 2025 Results
Legacy Housing Corporation Reports Third Quarter 2025 Financial and Operating Results
ASSOCIATED CAPITAL GROUP, INC. (OTCQX: ACGP) Reports Third Quarter Results
GAMCO Investors, Inc. Reports Results for the Third Quarter 2025
GAMCO Investors, Inc. Reports Results for the Third Quarter 2025
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NI Holdings, Inc. Reports Results for Third Quarter Ended September 30, 2025
Allcarestore.com Emerges as Fast-Growing Online Healthcare Retailer, Revolutionizing Access to Wellness Products
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update
Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions